|
Volumn 6, Issue 3, 2002, Pages 214-218
|
Concomitant basiliximab with low-dose calcineurin inhibitors in children post-liver transplantation
a a a a a |
Author keywords
Acute cellular rejection; Basiliximab; CNI drugs; Nephrotoxicity; Paediatric liver transplantation
|
Indexed keywords
AZATHIOPRINE;
CALCINEURIN INHIBITOR;
CISPLATIN;
CYCLOSPORIN;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RIBAVIRIN;
TACROLIMUS;
VANCOMYCIN;
BASILIXIMAB;
CALCINEURIN;
HYBRID PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR;
MONOCLONAL ANTIBODY;
ARTERY THROMBOSIS;
ARTICLE;
CALCULATION;
CASE REPORT;
CELL PROLIFERATION;
CHRONIC DISEASE;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DRUG TOLERABILITY;
FEMALE;
FOLLOW UP;
GIANT CELL;
GLOMERULUS FILTRATION RATE;
GRAFT REJECTION;
HEPATIC ARTERY;
HEPATITIS;
HEPATOBLASTOMA;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TRANSPLANTATION;
MALE;
NEPHROTOXICITY;
POSTOPERATIVE COMPLICATION;
PRESCHOOL CHILD;
RECEPTOR BINDING;
RECURRENT DISEASE;
REOPERATION;
SCHOOL CHILD;
T LYMPHOCYTE ACTIVATION;
CHEMICALLY INDUCED DISORDER;
CHILD;
DRUG ANTAGONISM;
DRUG COMBINATION;
DRUG EFFECT;
GRAFT SURVIVAL;
INFANT;
KIDNEY DISEASE;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
CALCINEURIN;
CHILD;
DRUG THERAPY, COMBINATION;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
INFANT;
KIDNEY DISEASES;
LIVER TRANSPLANTATION;
MALE;
RECEPTORS, INTERLEUKIN-2;
TREATMENT OUTCOME;
HUMANS;
RECOMBINANT FUSION PROTEINS;
|
EID: 0036022210
PISSN: 13973142
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-3046.2002.01076.x Document Type: Article |
Times cited : (26)
|
References (29)
|